Publication in "Nature–Scientific Reports"
Epalinges, Switzerland, March 24, 2022 - Mymetics Corporation (OTCQB: MYMX), a pioneer in the research and development of virosome based vaccines and immunotherapies against human life disabling and infectious diseases, announced today a publication in Nature Scientific Reports in collaboration with the AMC – Amsterdam University Medical Center, with title: “A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike”.
| Media Name | Media Type | Description | Download |
|---|